diagnostics Review Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19 Sebastiano Cicco 1,* , Antonio Vacca 2 , Christel Cariddi 3, Rossella Carella 1, Gianluca Altamura 3, Antonio Giovanni Solimando 1 , Gianfranco Lauletta 1 , Fabrizio Pappagallo 1, Anna Cirulli 1, Assunta Stragapede 1, Nicola Susca 1, Salvatore Grasso 3,† and Roberto Ria 1,† 1 Internal Medicine Unit “Guido Baccelli”, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Azienda Ospedaliero-Universitaria Policlinico, Piazza G. Cesare 11, I-70124 Bari, Italy;
[email protected] (R.C.);
[email protected] (A.G.S.);
[email protected] (G.L.);
[email protected] (F.P.);
[email protected] (A.C.);
[email protected] (A.S.);
[email protected] (N.S.);
[email protected] (R.R.) 2 Division of Internal Medicine, Department of Medicine, Building 8, University of Udine, I-33100 Udine, Italy;
[email protected] 3 Anesthesiology and Intensive Care Unit, Department of Emergency and Organ Transplantation (DETO) Ospedale Policlinico, University of Bari Aldo Moro, Azienda Ospedaliero-Universitaria Policlinico, Piazza G. Cesare 11, I-70124 Bari, Italy;
[email protected] (C.C.);
[email protected] (G.A.);
[email protected] (S.G.) * Correspondence:
[email protected] or
[email protected]; Tel.: +39-080-559-2859 † Equally contributed. Abstract: Coronavirus Disease 2019 (COVID-19) has been a pandemic challenge for the last year. Citation: Cicco, S.; Vacca, A.; Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to Cariddi, C.; Carella, R.; Altamura, G.; the disease severity and progression.